Neurology Today

Application holders for #GLP1 receptor agonists must now add info about a potential increased risk for a type of optic #neuropathy to the drug’s warnings: hubs.la/Q04DWyQV0

#NeuroTwitter #NAION #ophthalmology #EyeHealth

Studies have concluded that targeted screening for unruptured intracranial #aneurysms was either cost-effective or cost-saving: hubs.la/Q04DFvY30

#NeuroTwitter #neurology @ZanatyMario @uihealthcare @nyulangone

A weekly subcutaneous nanobody therapy and complement 5-inhibitor has produced strong outcomes in #MyastheniaGravis: hubs.la/Q04DFsNb0

#NeuroTwitter #neurology #gefurulimab @HopkinsMedicine @UCSFMedicine

Researchers searching for clues to neurologic disease have begun to increasingly look beyond the brain and into the gut: hubs.la/Q04DFl8M0

#NeuroTwitter #neurology #GutMicrobiome @CWRUSOM @Stanford_Neuro @OhioStateNeuro @OhioStateMed @EmeranMayerMD

A #wearable device estimated plasma #levodopa from passively collected sweat, and those numbers correlated with blood measurements in people with #Parkinsons disease: hubs.la/Q04DCWp30

#NeuroTwitter #NeurologyToday @JWangnano @ucsdneurodept @USFHealth @UCSDJacobs